Source:http://linkedlifedata.com/resource/pubmed/id/16516462
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2006-5-9
|
pubmed:abstractText |
In this study, we evaluated the possible role of Growth Hormone Receptor (GHR) expression pattern in determining rectal cancer radiosensitivity. We examined GHR expression in pre-treatment biopsy materials and post-operative specimens from 98 patients by immunohistochemistry (IHC) and reverse transcription-polymerase chain reaction (RT-PCR). GHR expression was evaluated for association with tumour radiosensitivity, which was defined according to Rectal Cancer Regression Grade (RCRG). IHC results demonstrated that GHR overexpression was significantly associated with a poor response to radiotherapy (P < 0.001, r(s) = 0.399); RT-PCR detection of GHR expression on pre-radiation biopsy specimens also showed that GHR mRNA negative group had a higher radiation sensitivity (P < 0.001, r(s) = 0.398). Compared with the pre-radiation biopsy specimens, the paired post-operative specimens showed a significantly up-regulated GHR expression in the reliquus cancer cells (P < 0.001). In conclusion, GHR expression levels may be an indicator for rectal cancer radiosensitivity before pre-operative irradiation. The administration of GHR antagonist may have the potential to increase rectal cancer radiosensitivity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0959-8049
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
888-94
|
pubmed:meshHeading |
pubmed-meshheading:16516462-Adult,
pubmed-meshheading:16516462-Aged,
pubmed-meshheading:16516462-Female,
pubmed-meshheading:16516462-Humans,
pubmed-meshheading:16516462-Immunohistochemistry,
pubmed-meshheading:16516462-Male,
pubmed-meshheading:16516462-Middle Aged,
pubmed-meshheading:16516462-Neoplasm Proteins,
pubmed-meshheading:16516462-Preoperative Care,
pubmed-meshheading:16516462-Radiation Tolerance,
pubmed-meshheading:16516462-Receptors, Somatotropin,
pubmed-meshheading:16516462-Rectal Neoplasms,
pubmed-meshheading:16516462-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16516462-Statistics, Nonparametric
|
pubmed:year |
2006
|
pubmed:articleTitle |
Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy.
|
pubmed:affiliation |
Nanjing University School of Medicine, Department of General Surgery of Jinling Hospital, 305 Zhong-shan-dong Road, Nanjing 210002, JS, PR China. wuxiaoyu@medmail.com.cn
|
pubmed:publicationType |
Journal Article
|